PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma (PaCaReg)

University of Ulm

Status: Enrolling

Conditions: Pancreas Adenocarcinoma; Pancreas Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT04099134

PaCaReg

Details and patient eligibility

About

PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma

Enrollment: 5,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
• Age =>18 years
• written informed consent

Exclusion criteria

• papillary cancer
• neuroendocrine pancreatic tumors